GEASTATIONAL DIABETES-- DETECTION AND CLINICAL INTERVENTION
妊娠期糖尿病——检测和临床干预
基本信息
- 批准号:3898759
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Gestational diabetes mellitus constitutes a large majority of
patients with diabetes seen during pregnancy. Even though
gestational diabetes comprises a major public health problem, its
diagnosis, pathophysiology, management and the evaluation of its
natural history has not received significant attention.
Nevertheless, gestational diabetes results in significant perinatal
morbidity in addition to the long term risk to the mother. The
overall aim of the proposed studies is to test the hypothesis that
gestational diabetes can be detected early in pregnancy in a high
risk population and that early intervention will decrease the
perinatal morbidity and mortality. A second aim is to test the
efficacy of diet and diet plus insulin for the clinical management
of gestational diabetes. It is hypothesized that dietary
regulation of disturbed metabolism of gestational diabetes will
not be able to optimally control metabolism. Other second- ary
aims that will evolve from these studies would be to define
criteria for glucose intolerance early in pregnancy specifically
in relation to perinatal outcome and to evaluate whether
characterization of gestationally diabetic women by their insulin
response to glucose load can help in classifying these patients in
relation to their clinical course and perinatal outcome.
Finally, this clinical core protocol will provide and characterize
the subject population for other studies in the perinatal Emphasis
Research Center (PERC). These studies are important because they
have a direct relation to an important clinical problem and would
provide the basis for the management of gestational diabetes.
妊娠期糖尿病占绝大多数
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROGER H. HERTZ其他文献
ROGER H. HERTZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROGER H. HERTZ', 18)}}的其他基金
SUBCUTANEOUS INSULIN INFUSION DURING AND PRIOR TO PREGNANCY
怀孕期间和怀孕前皮下胰岛素输注
- 批准号:
3974390 - 财政年份:
- 资助金额:
-- - 项目类别:
PREGNANCY AT RISK FOR INTRAUTERINE GROWTH RETARDATION--INSULIN INFUSION
妊娠有宫内生长迟缓的风险——胰岛素输注
- 批准号:
3966191 - 财政年份:
- 资助金额:
-- - 项目类别:
GESTATIONAL DIABETES--DETECTION AND CLINICAL INTERVENTION
妊娠期糖尿病——检测和临床干预
- 批准号:
3842596 - 财政年份:
- 资助金额:
-- - 项目类别:
PREGNANCY AT RISK FOR INTRAUTERINE GROWTH RETARDATION--INSULIN INFUSION
妊娠有宫内生长迟缓的风险——胰岛素输注
- 批准号:
3942422 - 财政年份:
- 资助金额:
-- - 项目类别:
GEASTATIONAL DIABETES-- DETECTION AND CLINICAL INTERVENTION
妊娠期糖尿病——检测和临床干预
- 批准号:
3919592 - 财政年份:
- 资助金额:
-- - 项目类别: